Show Summary Details
Page of

Primary and secondary prevention strategies in atherosclerosis 

Primary and secondary prevention strategies in atherosclerosis
Primary and secondary prevention strategies in atherosclerosis

Stephen J. Nicholls

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 04 July 2020

Atherosclerotic cardiovascular disease is the leading cause of mortality worldwide. Over the course of the last three decades, large-scale clinical trials have established that medical interventions that target major cardiovascular risk factors have a beneficial effect on clinical event rates in the settings of primary and secondary prevention. Despite widespread use of these therapies, there remains a substantial residual risk of clinical events. This highlights the need for more intensive risk factor modification and development of new approaches to the prevention of cardiovascular disease. The current approach to risk stratification and treatment of patients and potential targets for development of new therapies will be reviewed.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.